Vaccine induced a neutralising antibody response in 59% (148/253) & 47% (61/129) participants, & binding antibody response in 96% (244/253) & 97% (125/129) participants, in high & low dose groups, respectively, by day 28. Participants in placebo group showed no antibody increase

— The Lancet (@TheLancet) July 20, 2020